Benjamin Emmanuel

机构：AstraZeneca (Switzerland), AstraZeneca (Japan), AstraZeneca (Poland), AstraZeneca (United States) · ORCID：0000-0003-1769-9826

发表论文 98 篇 · 总被引 1593 次 · h-index 23

代表论文

• Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study (2025 · Advances in Therapy · 被引 25)
• Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics (2025 · American Journal of Respiratory and Critical Care Medicine · 被引 20)
• Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data (2025 · The Journal of Allergy and Clinical Immunology In Practice · 被引 15)
• XALOC-1 (2025 · CHEST Journal · 被引 15)
• Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC ‐2 (2025 · Clinical & Experimental Allergy · 被引 5)
• Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: The CLEAR Study (2025 · Pragmatic and Observational Research · 被引 4)